David Stolick, Chief Financial Officer at BRAINSTORM CELL THERAPEUTICS INC (BCLI), sold 100,000 shares at $0.36 ($36K) on 2010-02-22, disclosed to the SEC on 2010-02-23.
Scheduled sale ($36k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.